Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET

Private MD News

Home | News | Prostate

Protein may indicate the severity of prostate cancer

Category: Prostate

Protein may indicate the severity of prostate cancer

According to new research, which was funded by Cancer Research UK and published in the journal Nature Cell Biology, testing for a protein that may be able to indicate how severe a person's prostate cancer will be.

The study showed that the protein is responsible for keeping cells tightly connected and preserving the tissue's structure, which helps prevent cancerous cells from spreading. Not only does this indicate how lethal the prostate cancer is, but it can also be a predictor for its recurrence.

"Our findings indicate that the loss of β2-syntrophin at cell-to-cell connections in the prostate is an indicator of prostate cancer progression and patients with reduced levels of this protein at these cell-to-cell connections are more likely to have a recurrence of their cancer after treatment," said research author Natalie Mack, M.D.

The authors also noted that further research on the protein should be conducted so healthcare providers can tell the risk level of patients who are diagnosed with prostate cancer, so they can be treated effectively.

Prostate cancer risk factors
According to the National Institutes of Health (NIH), African American men, men who are older than 60 and men who have an immediate relative with prostate cancer are at a high risk of being diagnosed with the disease. Other at-risk groups include men who abuse alcohol, farmers, men who eat a high-fat diet and painters.

Gauging severity
The NIH notes that prostate cancer can be diagnosed with a prostate-specific antigen (PSA) blood test the severity of prostate cancer is gauged with a Gleason grade, which is based off of the imaging of a biopsied tumor. The three levels of severity are low-grade prostate cancer, intermediate prostate cancer and high-grade prostate cancer.

Treatment
There are a variety of treatments for the cancer and the Gleason score partially influences which one is used. These include surgery, radiation therapy and hormone therapy.


Related Articles from Private MD:

Share on Facebook

Subscribe to Private MD Health News RSS Feed: Subscribe

News Categories:

Advanced Lipid Treatment I   Allergy Testing   Anemia and RBC disorders   Autoimmune Diseases   Bariatric Lab Testing   Blood and Blood Diseases   Breast   Cancer Detection and Tumor Markers   Celiac Disease Testing   Chlamydia   Coagulation and blood clotting disorders   Colon   Diabetes   DNA, Paternity and Genetic testing   Drug Screening   Environmental Toxin Testing   Female Specific Tests   Gastrointestinal Diseases   General Health   General Wellness   Heart Health and Cholesterol   Herpes   HIV   HIV monitoring/Treatment/Testing/Post Diagnos   Hormones and Metabolism   Infectious Diseases   Infertility Testing-Male   Infertitlity Hormone Testing   Kidney Diseases   Leukemia and WBC disorders   Liver   Liver Diseases   Lyme Disease   Male Specific Tests   Menopause/Peri-Menopausal Diagnosis   Musculoskeletal Diseases   Organ Specific Testing   Ovarian   Prostate   Sexually Transmitted Diseases   Thyroid Diseases   Transgender Hormone Testing-female to male   Transgender Hormone Testing-Male to Female   Vitamin D Deficiency-Diagnosis and Treatment   

Visit the Health News Archive: Click Here

Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.

Back to top